FDA
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
-
-
-
-
-
-
-
Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE
-
-
-
-
-
-
-
Rhythm Pharmaceuticals gets European panel backing for obesity drug
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
-
323,128 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

